QA/QC Tools - GMP - FDA - EMA
Audit Readiness Checklist
Self-assess GMP inspection readiness across documentation, pharmaceutical quality system, CAPA, deviations, validation, data integrity, facilities, and equipment. Built for QA leads, quality managers, and inspection response teams — then verify against site SOPs and regulatory guidance.
Quick Answer
GMP audit readiness is the documented state of being prepared for FDA, EMA, or PIC/S inspection. Quality teams score documentation, pharmaceutical quality system governance, CAPA effectiveness, validation status, data integrity controls, and facility readiness against objective evidence. This interactive checklist produces a risk-based readiness score and prioritized gap action list for self-inspection and pre-approval inspection preparation — reconcile results with site SOPs and current ICH Q10/Q9 guidance.
Inspection readiness score
Mark checklist items below to generate a readiness view and prioritized gap list.
0%
Mark checklist items to generate a readiness view.
FDA/EMA GMP Readiness Checklist
Use documentary evidence when scoring. Examples include approved SOPs, training records, audit reports, batch records, deviation files, validation protocols, data audit trails, calibration logs, and environmental monitoring records.
Documentation and Record Control
Current approved SOPs are available for GMP-critical operations and reflect actual practice.
Batch production and laboratory records are complete, attributable, legible, contemporaneous, original, and accurate.
Document change history, periodic review, retention, and archival processes are controlled.
Pharmaceutical Quality System
Management review evaluates quality metrics, recurring deviations, complaints, recalls, and CAPA effectiveness.
Quality risk management is documented and aligned with ICH Q9 principles.
Supplier qualification and quality agreements are current for critical materials and services.
CAPA, Deviations, OOS and Complaints
Deviation and OOS investigations identify root cause, product impact, and scientifically justified conclusions.
CAPA actions have owners, due dates, verification of effectiveness, and overdue escalation.
Complaint, recall, and field alert processes are tested and traceable to batch distribution records.
Process, Cleaning and Computerized System Validation
Process validation lifecycle files include approved protocols, reports, CPP/CQA rationale, and continued process verification.
Cleaning validation limits, sampling plans, recovery factors, and residue methods are justified and current.
Computerized systems have validation status, access control, backup/restore testing, and change control evidence.
Data Integrity and Laboratory Controls
Audit trails for critical GMP systems are enabled, reviewed, and linked to defined procedures.
Analytical methods, reference standards, sample handling, and chromatographic integration practices are controlled.
User access, shared accounts, electronic signatures, and privileged permissions are periodically reviewed.
Facilities, Utilities and Equipment
Critical utilities, HVAC, water systems, and cleanrooms are qualified, monitored, and maintained within alert/action limits.
Calibration and preventive maintenance records are current for GMP-critical instruments and equipment.
Line clearance, material/personnel flow, pest control, and housekeeping controls are inspection-ready.
Gap Action List
Items marked partial or fail will appear here with suggested remediation priority.
How to Interpret the Score
Pharma & inspection context
GMP audit readiness is a core responsibility under ICH Q10 pharmaceutical quality system and EU GMP Chapter 9 self-inspection requirements. Sponsors, CMOs, and API manufacturers use structured readiness assessments before FDA pre-approval inspections, EMA GMP inspections, client audits, and remediation milestones following prior 483 observations or warning letters.
This checklist integrates with the NovaPharmaNews QA/QC hub: generate site-specific checklists with the GMP Checklist Generator, prioritize process failures with the RPN Calculator, assess process capability with Process Capability Cpk, and calculate cleaning validation limits with the Cleaning Validation Limit tool.
Inspection readiness should link to management review metrics, deviation trending, CAPA overdue reports, and validation status dashboards. Document self-inspection findings in the quality system and track closure before scheduling regulatory-facing activities.
Evidence & sources
- FDA cGMP Regulations (21 CFR 210/211)
- FDA Guidance: Process Validation — General Principles and Practices
- EMA Good Manufacturing Practice (EU GMP)
- ICH Q9(R1) Quality Risk Management and ICH Q10 Pharmaceutical Quality System
- WHO Technical Report Series — GMP for pharmaceutical products
- Competitive landscape: Pharmaguddu QA Audit Checklist provides static department-specific checklist articles useful for reference but lacks interactive scoring, gap prioritization, or integrated QA/QC tool cross-links. FDA cGMP Resources are authoritative for inspection scope but offer no self-assessment workflow. NovaPharmaNews provides a free interactive readiness score with prioritized gap actions and full QA/QC hub links — no login required.